Search

Author/Creator Yu, Kunlin

1. Betulinic acid restores imatinib sensitivity in BCR‐ABL1 kinase−independent, imatinib‐resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation. Issue 1 (13th January 2020)

Authors:
Lu, Tingting; Wei, Danna; Yu, Kunlin; Ma, Dan; Xiong, Jie; Fang, Qin; Wang, Jishi
Journal:
Annals of the New York Academy of Sciences
Issue:
Volume 1467:Issue 1(2020)
Page Start:
77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia. Issue 2 (February 2020)

Authors:
Zhang, Tianzhuo; Ma, Dan; Wei, Danna; Lu, Tingting; Yu, Kunlin; Zhang, Zhaoyuan; Wang, Weili; Fang, Qin; Wang, Jishi
Journal:
Anti-cancer drugs
Issue:
Volume 31:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Overexpression of heme oxygenase‐1 in microenvironment mediates vincristine resistance of B‐cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion. Issue 10 (2nd July 2019)

Authors:
Yu, Kunlin; Wang, Jishi; Lu, Tingting; Ma, Dan; Wei, Danna; Guo, Yongling; Cheng, Bingqin; Wang, Weili; Fang, Qin
Journal:
Journal of cellular biochemistry
Issue:
Volume 120:Issue 10(2019)
Page Start:
17791
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗